Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Prostate Cancer | Research

Effect of health belief model-based educational intervention on prostate cancer prevention; knowledge, practices, and intentions

Authors: Marwa Ibrahim Mahfouz Khalil, Ayat Ashour, Reem Said Shaala, Rasha Mahmoud Allam, Thoraya Mohamed Abdelaziz, Enas Fouad Sayed Mousa

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Prostate cancer screening is a crucial preventive element for improving the survival rates of prostate cancer. Therefore, our research objective was to investigate the effect of health belief model-based education on prostate cancer knowledge, health beliefs, and preventive health practices among adult and older adult males.

Methods

A one-group pre-test/post-test quasi-experimental study design was carried out at the one-day outpatient clinics affiliated to General Alexandria Main University Hospital. We enrolled 110 men aged 45–75 years old in a health belief model-based educational intervention program. Various questionnaires were utilized to gather data before, immediately after, and three months following the intervention. These questionnaires included the socio-demographic questionnaire, Prostate Cancer Knowledge Questionnaire (PCKQ), Prostate Cancer Screening-Health Belief Model Scale (HBM-PCS), Prostate Cancer Preventive Practices Questionnaire (PCPPQ), and one question regarding the intention to undergo PC screening.

Results

Participants’ knowledge about prostate cancer screening improved significantly immediately after the program and this positive change was maintained at the follow-up (p = 0.000). Furthermore, participants’ perceptions and preventive practices towards prostate cancer screening had changed significantly after program completion and at follow-up (p = 0.000). After program completion, many of the participants (92.7%) expressed their intention to undergo prostate cancer screening within the coming six months (p = 0.000). The younger age group (45–49 years) showed higher scores in their perception of prostate screening (p = 0.001). Higher education and income were significantly associated with higher scores in the three scales (p = 0.000 in all scales).

Conclusion

The study findings emphasized the effectiveness of the designed health educational program based on the HBM on PC preventive behaviors, through significantly improving participants’ knowledge level, perceptions, practices, and intentions to PC screening. The program is highly recommended for prostate cancer preventive health practices among both adult and older adult males.
Appendix
Available only for authorised users
Literature
3.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021;71(3):209– 49. https://doi.org/10.3322/caac.21660. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021;71(3):209– 49. https://​doi.​org/​10.​3322/​caac.​21660.
4.
go back to reference Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology. 2017;3(4):524– 48. https://doi.org/10.1001/jamaoncol.2016.5688. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology. 2017;3(4):524– 48. https://​doi.​org/​10.​1001/​jamaoncol.​2016.​5688.
7.
8.
go back to reference Cancer Research UK. Cancer Statistics for the UK 2015 [cited 2015 27th July]. Cancer Research UK. Cancer Statistics for the UK 2015 [cited 2015 27th July].
12.
14.
go back to reference Morrison BF, Aiken WD, Mayhew R, Gordon Y, Odedina FT. Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men. Journal of cancer education: the official journal of the American Association for Cancer Education. 2017;32(2):352– 6. https://doi.org/10.1007/s13187-016-0991-8. Morrison BF, Aiken WD, Mayhew R, Gordon Y, Odedina FT. Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men. Journal of cancer education: the official journal of the American Association for Cancer Education. 2017;32(2):352– 6. https://​doi.​org/​10.​1007/​s13187-016-0991-8.
15.
go back to reference American Cancer Society. Cancer Facts & Fig. 2021. Atlanta, Ga: American Cancer Society; 2021. American Cancer Society. Cancer Facts & Fig. 2021. Atlanta, Ga: American Cancer Society; 2021.
17.
go back to reference World Health Organization. Regional Office for the Western P. Sustainable development goals (SDGs): Goal 3. Target 3.4: By 2030, By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well being [poster]. Manila: WHO Regional Office for the Western Pacific; 2016, 2016. World Health Organization. Regional Office for the Western P. Sustainable development goals (SDGs): Goal 3. Target 3.4: By 2030, By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well being [poster]. Manila: WHO Regional Office for the Western Pacific; 2016, 2016.
18.
go back to reference Riekert KA, Ockene JK, Pbert L. The handbook of health behavior change. Springer Publishing Company; 2013. Riekert KA, Ockene JK, Pbert L. The handbook of health behavior change. Springer Publishing Company; 2013.
19.
go back to reference Çapık C, Gözüm S. Development and Validation of Health beliefs Model Scale for prostate Cancer screenings (HBM-PCS): evidence from exploratory and confirmatory factor analyses. Int J Cancer Biomedical Res. 2011;15(5):478–85. Çapık C, Gözüm S. Development and Validation of Health beliefs Model Scale for prostate Cancer screenings (HBM-PCS): evidence from exploratory and confirmatory factor analyses. Int J Cancer Biomedical Res. 2011;15(5):478–85.
20.
go back to reference Friedman DB, Thomas TL, Owens OL, Hébert JR. It takes two to talk about prostate Cancer: a qualitative Assessment of African American men’s and women’s Cancer Communication practices and recommendations. J Cancer Education: Official J Am Association Cancer Educ. 2012;6(6):472–84. Friedman DB, Thomas TL, Owens OL, Hébert JR. It takes two to talk about prostate Cancer: a qualitative Assessment of African American men’s and women’s Cancer Communication practices and recommendations. J Cancer Education: Official J Am Association Cancer Educ. 2012;6(6):472–84.
21.
go back to reference Berger J, Bayarri M, Pericchi LJER. Effective Sample size. 2014;33(1–4):197–217. Berger J, Bayarri M, Pericchi LJER. Effective Sample size. 2014;33(1–4):197–217.
22.
go back to reference Agho AO, Lewis MA. Correlates of actual and perceived knowledge of prostate Cancer among African americans. Cancer Nurs. 2001;24(3):165–71.CrossRefPubMed Agho AO, Lewis MA. Correlates of actual and perceived knowledge of prostate Cancer among African americans. Cancer Nurs. 2001;24(3):165–71.CrossRefPubMed
23.
go back to reference Weinrich SP, Seger R, Curtsinger T, Pumphrey G, NeSmith EG, Weinrich MC. Impact of Pretest on Posttest Knowledge scores with a Solomon Four Research Design. Res Theory Nurs Pract. 2007;30(5):E16–E28. Weinrich SP, Seger R, Curtsinger T, Pumphrey G, NeSmith EG, Weinrich MC. Impact of Pretest on Posttest Knowledge scores with a Solomon Four Research Design. Res Theory Nurs Pract. 2007;30(5):E16–E28.
25.
go back to reference Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, Andrews KS, Bandera EV, Spees CK, Robien K, Hartman S, Sullivan K, Grant BL, Hamilton KK, Kushi LH, Caan BJ, Kibbe D, Black JD, Wiedt TL, McMahon C, Sloan K, Doyle C. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70(4):245–71. https://doi.org/10.3322/caac.21591.CrossRefPubMed Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, Andrews KS, Bandera EV, Spees CK, Robien K, Hartman S, Sullivan K, Grant BL, Hamilton KK, Kushi LH, Caan BJ, Kibbe D, Black JD, Wiedt TL, McMahon C, Sloan K, Doyle C. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70(4):245–71. https://​doi.​org/​10.​3322/​caac.​21591.CrossRefPubMed
26.
go back to reference Brookman-May SD, Campi R, Henriquez JD, Klatte T, Langenhuijsen JF, Brausi M et al. Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). 2019;5(5):756–87. Brookman-May SD, Campi R, Henriquez JD, Klatte T, Langenhuijsen JF, Brausi M et al. Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). 2019;5(5):756–87.
28.
go back to reference Anderson MM. Testing the health belief model using prostate cancer screening intention: comparing four statistical approaches applied to data from the 2008-09 Nashville Men’s Preventive Health Survey. Journal of Men’s Health; 2013. Anderson MM. Testing the health belief model using prostate cancer screening intention: comparing four statistical approaches applied to data from the 2008-09 Nashville Men’s Preventive Health Survey. Journal of Men’s Health; 2013.
29.
go back to reference Zare M, Ghodsbin F, Jahanbin I, Ariafar A, Keshavarzi S, Izadi T. The Effect of Health Belief Model-based education on knowledge and prostate Cancer screening behaviors: a Randomized Controlled Trial. J Interventional Cancer Epidemiol Prev. 2016;4(1):57. Zare M, Ghodsbin F, Jahanbin I, Ariafar A, Keshavarzi S, Izadi T. The Effect of Health Belief Model-based education on knowledge and prostate Cancer screening behaviors: a Randomized Controlled Trial. J Interventional Cancer Epidemiol Prev. 2016;4(1):57.
30.
go back to reference Maladze N, Maphula A, Maluleke M, Makhado L. Knowledge and attitudes towards prostate Cancer and screening among males in Limpopo Province, South Africa. Int J Environ Res Public Health. 2023;20(6):5220.CrossRefPubMedCentralPubMed Maladze N, Maphula A, Maluleke M, Makhado L. Knowledge and attitudes towards prostate Cancer and screening among males in Limpopo Province, South Africa. Int J Environ Res Public Health. 2023;20(6):5220.CrossRefPubMedCentralPubMed
31.
go back to reference Baratedi WM, Tshiamo WB, Mogobe KD, McFarland DM. Barriers to prostate cancer screening by men in Sub-saharan Africa: an integrated review. J Nurs Scholarsh. 2020;52(1):85–94.CrossRefPubMed Baratedi WM, Tshiamo WB, Mogobe KD, McFarland DM. Barriers to prostate cancer screening by men in Sub-saharan Africa: an integrated review. J Nurs Scholarsh. 2020;52(1):85–94.CrossRefPubMed
33.
go back to reference Bilgili N, Kitiş Y. Prostate Cancer Screening and Health beliefs: a Turkish study of male adults. Eur J Med Health Sci. 2019;41(2). Bilgili N, Kitiş Y. Prostate Cancer Screening and Health beliefs: a Turkish study of male adults. Eur J Med Health Sci. 2019;41(2).
34.
go back to reference Oliver JS, Grindel CG, DeCoster J, Ford CD, Martin MY. Benefits, barriers, sources of influence, and prostate cancer screening among rural men. Public Health Nurs. 2011 Nov-Dec;28(6):515–22. Oliver JS, Grindel CG, DeCoster J, Ford CD, Martin MY. Benefits, barriers, sources of influence, and prostate cancer screening among rural men. Public Health Nurs. 2011 Nov-Dec;28(6):515–22.
35.
go back to reference Najimeh Beygi Z, Alizadeh Z, Fereidouni T, Mokhlesabadifarahani NNN, Abadi S, Soudagar, Afsaneh Ghasemi. Evaluation of the Effect of Health Belief Model Based Training on Health Performance of Male Staff in Fasa University of Medical Science in the field of prostate Cancer. J Complement Med Res. 12(3), 158–64. https://doi.org/10.5455/jcmr.2021.12.03.21. Najimeh Beygi Z, Alizadeh Z, Fereidouni T, Mokhlesabadifarahani NNN, Abadi S, Soudagar, Afsaneh Ghasemi. Evaluation of the Effect of Health Belief Model Based Training on Health Performance of Male Staff in Fasa University of Medical Science in the field of prostate Cancer. J Complement Med Res. 12(3), 158–64. https://​doi.​org/​10.​5455/​jcmr.​2021.​12.​03.​21.
36.
go back to reference Dehghan HJT. Effect of education on preventive treatment of prostate cancer in men over 40 years of Yazd. Health Belief Model. 2017;15(5):31–43. Dehghan HJT. Effect of education on preventive treatment of prostate cancer in men over 40 years of Yazd. Health Belief Model. 2017;15(5):31–43.
37.
go back to reference Lee E, Park Y, Park JJOJN. Knowledge, health beliefs and screening status of prostate cancer among middle-aged and elderly men. 2016;6(9):672–87. Lee E, Park Y, Park JJOJN. Knowledge, health beliefs and screening status of prostate cancer among middle-aged and elderly men. 2016;6(9):672–87.
38.
go back to reference Gift S, Nancy K, Victor MJAJU. Assessment of knowledge, practice and attitude towards prostate cancer screening among male patients aged 40 years and above at Kitwe Teaching Hospital. Zambia. 2020;26:1–7. Gift S, Nancy K, Victor MJAJU. Assessment of knowledge, practice and attitude towards prostate cancer screening among male patients aged 40 years and above at Kitwe Teaching Hospital. Zambia. 2020;26:1–7.
41.
go back to reference Mason RJ, Marzouk K, Finelli A, Saad F, So AI, Violette PD, Breau RH, Rendon RA. UPDATE– 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging. Can Urol Assoc J. 2022;16(4):E184–96. https://doi.org/10.5489/cuaj.7851.CrossRefPubMedCentralPubMed Mason RJ, Marzouk K, Finelli A, Saad F, So AI, Violette PD, Breau RH, Rendon RA. UPDATE– 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging. Can Urol Assoc J. 2022;16(4):E184–96. https://​doi.​org/​10.​5489/​cuaj.​7851.CrossRefPubMedCentralPubMed
42.
go back to reference Kaninjing E, Lopez I, Nguyen J, Odedina F, Young ME. Prostate Cancer screening perception, beliefs, and practices among men in Bamenda, Cameroon. Am J Mens Health. 2018;12(5):1463–72. Epub 2018 Apr 16.CrossRefPubMedCentralPubMed Kaninjing E, Lopez I, Nguyen J, Odedina F, Young ME. Prostate Cancer screening perception, beliefs, and practices among men in Bamenda, Cameroon. Am J Mens Health. 2018;12(5):1463–72. Epub 2018 Apr 16.CrossRefPubMedCentralPubMed
Metadata
Title
Effect of health belief model-based educational intervention on prostate cancer prevention; knowledge, practices, and intentions
Authors
Marwa Ibrahim Mahfouz Khalil
Ayat Ashour
Reem Said Shaala
Rasha Mahmoud Allam
Thoraya Mohamed Abdelaziz
Enas Fouad Sayed Mousa
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12044-9

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine